Literature DB >> 29371072

Apixaban Causing Leukocytoclastic Vasculitis.

Usama Bin Nasir1, Aswini Kumar2, Arti Easwar3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29371072     DOI： 10.1016/j.jaip.2017.12.007

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  4 in total

1.  A rare case report of apixaban-induced lichenoid eruption.

Authors:  Tanvi Patil; Suzanne Hanna; Wayne Torre
Journal:  Ther Adv Drug Saf       Date:  2020-08-17

2.  Apixaban-induced cutaneous leucocytoclastic vasculitis.

Authors:  Munim Khan; Mahmoud Y Madi; Joseph Rencic
Journal:  BMJ Case Rep       Date:  2020-08-24

Review 3.  A 78-Year-Old Man with a Pulmonary Embolism Who Developed Skin Necrosis 7 Days After Treatment with the Direct Oral Anticoagulant Factor Xa Inhibitor Apixaban.

Authors:  Tusharkumar Pansuriya; Trung Nguyen; Mir Ali Sadat; Syed A Raza; Siva T Sarva
Journal:  Am J Case Rep       Date:  2021-01-25

4.  Complementary Use of U.S. FDA's Adverse Event Reporting System and Sentinel System to Characterize Direct Oral Anticoagulants-Associated Cutaneous Small Vessel Vasculitis.

Authors:  Mohamed Mohamoud; Casie Horgan; Efe Eworuke; Elizabeth Dee; Justin Bohn; Oren Shapira; Monica A Munoz; Danijela Stojanovic; Veronica Sansing-Foster; Adebola Ajao; Lois La Grenade
Journal:  Pharmacotherapy       Date:  2020-11-08       Impact factor: 6.251
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.